Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsThe HCPFive: Top News for Healthcare Providers from the Week of 10/25
Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab
A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.
Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.
Here's some of what is coming soon to NeurologyLive® this week.
Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.
ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know
1.
'Next Berlin Patient' Adds to Small but Growing Number of People Cured of HIV
2.
A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.
3.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
4.
Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends
5.
Q&A: When will individuals be able to receive customized cancer vaccines?
1.
Precision Supportive Oncology: Managing Immune Toxicity, Treatment-Related Critical Illness and Long-Term Quality of Life
2.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
3.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
4.
Tumor Clonal Evolution Through Single-Cell Genomics
5.
Women's Health Through Survivorship Research Focused on Female-Specific Cancer Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
2.
Recognizing General Warning Signs of Cancer
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
4.
Hands-on Workshop: Hematology
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge